266
Participants
Start Date
March 31, 2007
Primary Completion Date
July 31, 2008
Study Completion Date
July 31, 2008
aminolevulinic acid HCL (ALA)
Levulan Kerastick containing 20% aminolevulinic acid HCL (ALA). Up to 4 treatments will be given at 3 week intervals.
Vehicle (VEH)
Levulan Kerastick containing vehicle ingredients only (VEH). Up to 4 treatments will be given at 3 week intervals.
Downstate Med Ctr, Brooklyn
Penn State Milton S. Hershey Medical Center, Hershey
Gwinnett Clinical Research Center, Inc., Snellville
Kenneth R. Beer, M.D. P.A., West Palm Beach
Tennessee Clinical Research Center, Nashville
Derm Research PLLC, Louisville
Laser and Skin Surger Center of Indiana, Carmel
Minnesota Clinical Study Center, Fridley
Burke Pharmaceutical Research, Hot Springs
Baylor Research Institute, Dallas
Derm Research Inc, Austin
Cherry Creek Research, Inc., Denver
Dermatology Research Center, Inc., Salt Lake City
Therapeutics Clinical Research, San Diego
Lead Sponsor
DUSA Pharmaceuticals, Inc.
INDUSTRY